Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited)

v3.20.1
Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Equity Payable
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance, value at Dec. 31, 2018 $ 45,998 $ 100,862 $ 88,008,473 $ 4,759 $ (87,835,132) $ 324,960
Beginning balance, Shares at Dec. 31, 2018 45,998,053          
Issuance of common stock for cash $ 2,800 2,797,200 2,800,000
Issuance of common stock for cash, Shares 2,800,000          
Issuance of common stock for debt conversion $ 2,583 2,812,795 2,815,378
Issuance of common stock for debt conversion, Shares 2,582,916          
Stock based compensation 1,163,270 1,163,270
Foreign currency translation adjustment 4,021 4,021
Net income (loss) (8,821,974) (8,821,974)
Ending balance, value at Dec. 31, 2019 $ 51,381 100,862 94,781,738 8,780 (96,657,106) (1,714,345)
Ending balance, shares at Dec. 31, 2019 51,380,969          
Issuance of common stock for warrant conversion $ 235 234,265 $ 234,500
Issuance of common stock for warrant conversion, Shares 234,500          
Issuance of common stock for debt conversion, Shares           2,582,916
Stock based compensation 199,213 $ 199,213
Foreign currency translation adjustment (13,081) (13,081)
Net income (loss) (1,015,779) (1,015,779)
Ending balance, value at Mar. 31, 2020 $ 51,616 $ 100,862 $ 95,215,216 $ (4,301) $ (97,672,885) $ (2,309,492)
Ending balance, shares at Mar. 31, 2020 51,615,469